Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 718 clinical trials in Bilthoven, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma
The NetherlandsStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
The NetherlandsStudy on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin
The NetherlandsStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
The NetherlandsStudy of Pembrolizumab for Patients with Locally Advanced, Unresectable, Non-Metastatic Colorectal Cancer
The NetherlandsStudy on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
The NetherlandsLong-Term Safety Study of Riliprubart in Patients with Cold Agglutinin Disease
The NetherlandsStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
The NetherlandsStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
The NetherlandsLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
The NetherlandsStudy on the Safety and Efficacy of Viltolarsen for Boys with Duchenne Muscular Dystrophy
The NetherlandsStudy of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on optimizing vaccine effectiveness against multiple infectious diseases, including studies on meningococcal disease and influenza in different age groups.
Novel approaches include investigating optimal vaccination timing and early immunization strategies for enhanced protection.
Advanced studies in breast cancer treatment, examining innovative therapeutic combinations for hormone receptor-positive cases.
Investigations focus on optimizing treatment sequences to improve progression-free survival rates.
Clinical research examining surgical treatments combined with antibiotic therapy for improved patient outcomes.
Studies aim to enhance surgical outcomes through innovative combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
